August 7, 2013. Over 30 million Americans, including 2 million adolescents between age 11 and 18, use tanning devices each year. Those who began using tanning beds before age 30 are 75 percent more likely to develop cutaneous melanoma, a potentially fatal cancer.
Read More »On Medical Treatments & Products
Comments on Proposed Order “Requests for Ban or Standard on Adult Portable Bed Rails”
July 30, 2013. Comments of the National Research Center for Women & Families on Proposed Order “Requests for Ban or Standard on Adult Portable Bed Rails”: We are writing to urge the Consumer Product Safety Commission to take strong action to protect consumers from dangerous bed rails by either:
Read More »NCHR Testimony at FDA Advisory Committee on Implanted Blood Access Devices
June 27, 2016. FDA wanted to change implanted blood access devices, like catheters and cannulas, from a Class III device (highest standards) to a Class II device (lower standards). Senior fellow, Jennifer Yttri, spoke on behalf of NRC about how reclassification would limit the ability of FDA and patients to request more safety and efficacy testing and remove faulty devices from market.
Read More »NCHR Testimony at FDA on Sorbent Hemoperfusion Systems
June 27, 2013. These systems are used to filter toxins out of the blood . However, there is not proof that the devices save the lives of patients who are poisoned, have a drug overdose, or are in a coma from liver failure. Because of this lack of evidence, Dr Yttri and the NRC argued that these devices need to undergo clinical testing.
Read More »NCHR Testimony to FDA Advisory Committee on Avandia
June 6, 2013. We are disappointed that the FDA continues to waste their limited resources reopening what should be a closed case. If you are not ready to make that recommendation, then please keep the current safeguards in place.
Read More »